People · Operator
Named in public records as an officer, director or promoter · active 2022–2025 · Pharmaceuticals, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cxl Ophthalmics, Inc. | — | Pharmaceuticals | Series B | $26.4M | $369.7M | 2022 |
| Ocudyne, Inc. | — | Other Health Care | Series A | $10.1M | $21.9M | 2025 |
Jonathan Talamo at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jonathan Talamo on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Curt LaBelle | 1 | 7 |
| Joseph Smith | 1 | 7 |
| Michael Webb | 1 | 6 |
| Robert Atkinson | 1 | 3 |
| Joseph M. Smith | 1 | 3 |
| Marc Odrich | 1 | 2 |
| Jeffrey Franco | 1 | 2 |
| SUSAN MACDONALD | 1 | 1 |
| Edward Malouf | 1 | 1 |
| EDWARD PARSONS | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.